Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF

Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Rajkumar Savai(Goethe University Frankfurt), Werner Seeger(Justus-Liebig-Universität Gießen), Marten Szibor(Tampere University Hospital), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Thomas Braun(Justus-Liebig-Universität Gießen), Jochen Wilhelm(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Ewa Kołosionek(Medway School of Pharmacy), Dawid Pomagruk(Justus-Liebig-Universität Gießen), Jörg Hänze(Philipps University of Marburg), Gamal Andre Banat, Anja Schmall(Max Planck Institute for Heart and Lung Research)
Oncogene
April 23, 2012
10.1038/onc.2012.136
Cited by 139

Related Papers

Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784